
医学资讯帕博利珠单抗,四照射放疗,头颈癌,免疫检查点抑制剂
帕博利珠单抗联合四照射放疗:复发、不可切除头颈癌的潜力方案
By MedXY|2026年8月27日
2期试验显示,帕博利珠单抗联合低剂量四照射放疗可在复发、不可切除头颈部鳞状细胞癌中获得令人鼓舞的缓解率和生存结局。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.